Central Nervous System Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/central-nervous-system/ The leading site for news and procurement in the pharmaceutical industry Wed, 21 Aug 2024 13:42:19 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Central Nervous System Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/central-nervous-system/ 32 32 Organon and Lilly expand deal for migraine treatment to new markets https://www.pharmaceutical-technology.com/news/organon-lilly-migraine-treatment/ Wed, 21 Aug 2024 08:13:51 +0000 https://www.pharmaceutical-technology.com/news/organon-lilly-migraine-treatment/ UAE approves BioArctic and Eisai’s Leqembi for Alzheimer’s disease https://www.pharmaceutical-technology.com/news/bioarctic-eisai-leqembi-uae/ Wed, 14 Aug 2024 10:04:18 +0000 https://www.pharmaceutical-technology.com/news/bioarctic-eisai-leqembi-uae/ FDA rejects Lykos MDMA therapy, asks for another Phase III trial https://www.pharmaceutical-technology.com/news/fda-rejects-lykos-mdma-therapy-asks-for-another-phase-iii-trial/ Mon, 12 Aug 2024 12:16:25 +0000 https://www.pharmaceutical-technology.com/?p=326110 FDA approves Servier’s VORANIGO for IDH-mutant Grade 2 glioma https://www.pharmaceutical-technology.com/news/fda-servier-voranigo/ Wed, 07 Aug 2024 10:09:40 +0000 https://www.pharmaceutical-technology.com/news/fda-servier-voranigo/ Genentech and Sangamo to develop neurodegenerative disease therapies https://www.pharmaceutical-technology.com/news/genentech-sangamo-neurodegenerative-diseases/ Wed, 07 Aug 2024 08:22:11 +0000 https://www.pharmaceutical-technology.com/news/genentech-sangamo-neurodegenerative-diseases/ Vertex’s blockbuster-in-waiting painkiller suzetrigine set for FDA review next year https://www.pharmaceutical-technology.com/news/vertexs-blockbuster-in-waiting-painkiller-suzetrigine-set-for-fda-review-next-year/ Wed, 31 Jul 2024 15:36:50 +0000 https://www.pharmaceutical-technology.com/news/vertexs-blockbuster-in-waiting-painkiller-suzetrigine-set-for-fda-review-next-year/ Study finds semaglutide decreases tobacco-related healthcare https://www.pharmaceutical-technology.com/news/study-finds-semaglutide-decreases-tobacco-related-healthcare/ Tue, 30 Jul 2024 16:02:25 +0000 https://www.pharmaceutical-technology.com/news/study-finds-semaglutide-decreases-tobacco-related-healthcare/ Collegium buys Ironshore for $525m and enter ADHD market https://www.pharmaceutical-technology.com/news/collegium-buys-ironshore-for-525m-and-enter-adhd-market/ Tue, 30 Jul 2024 13:18:37 +0000 https://www.pharmaceutical-technology.com/news/collegium-buys-ironshore-for-525m-and-enter-adhd-market/ EU CHMP snubs Biogen and Eisai’s Alzheimer’s therapy Leqembi https://www.pharmaceutical-technology.com/news/eu-chmp-snubs-biogen-and-eisais-alzheimers-therapy-leqembi/ Mon, 29 Jul 2024 16:56:47 +0000 https://www.pharmaceutical-technology.com/news/eu-chmp-snubs-biogen-and-eisais-alzheimers-therapy-leqembi/ Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy https://www.pharmaceutical-technology.com/news/ipsen-outlines-461m-for-ex-us-rights-to-day-ones-glioma-therapy/ Thu, 25 Jul 2024 15:34:08 +0000 https://www.pharmaceutical-technology.com/news/ipsen-outlines-461m-for-ex-us-rights-to-day-ones-glioma-therapy/